Sources | Names Used |
---|---|
CTRPv2 | navitoclax:gemcitabine (1:1 mol/mol) |
PharmacoGx | navitoclax:gemcitabine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RP11-544M22.13 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
mRNA | ENY2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | CEP152 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | PLA2G6 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | DUS3L | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | SLC38A7 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | TTLL12 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | CCDC149 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | PROSC | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | CSK | CTRPv2 | pan-cancer | AAC | 0.13 | 0.003 |